129 related articles for article (PubMed ID: 9212243)
1. Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.
Thompson JA; Eades-Perner AM; Ditter M; Muller WJ; Zimmermann W
Int J Cancer; 1997 Jul; 72(1):197-202. PubMed ID: 9212243
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene.
Nöckel J; van den Engel NK; Winter H; Hatz RA; Zimmermann W; Kammerer R
BMC Cancer; 2006 Mar; 6():57. PubMed ID: 16536871
[TBL] [Abstract][Full Text] [Related]
3. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.
Wilkinson RW; Ross EL; Poulsom R; Ilyas M; Straub J; Snary D; Bodmer WF; Mather SJ
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10256-60. PubMed ID: 11517330
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.
Greiner JW; Zeytin H; Anver MR; Schlom J
Cancer Res; 2002 Dec; 62(23):6944-51. PubMed ID: 12460911
[TBL] [Abstract][Full Text] [Related]
5. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
Clarke P; Mann J; Simpson JF; Rickard-Dickson K; Primus FJ
Cancer Res; 1998 Apr; 58(7):1469-77. PubMed ID: 9537250
[TBL] [Abstract][Full Text] [Related]
6. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy.
Thompson J; Epting T; Schwarzkopf G; Singhofen A; Eades-Perner AM; van Der Putten H; Zimmermann W
Int J Cancer; 2000 Jun; 86(6):863-9. PubMed ID: 10842202
[TBL] [Abstract][Full Text] [Related]
8. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern.
Eades-Perner AM; van der Putten H; Hirth A; Thompson J; Neumaier M; von Kleist S; Zimmermann W
Cancer Res; 1994 Aug; 54(15):4169-76. PubMed ID: 8033149
[TBL] [Abstract][Full Text] [Related]
9. A new mouse model for evaluating the immunotherapy of human colorectal cancer.
Hörig H; Wainstein A; Long L; Kahn D; Soni S; Marcus A; Edelmann W; Kucherlapati R; Kaufman HL
Cancer Res; 2001 Dec; 61(23):8520-6. PubMed ID: 11731437
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
Szalai G; Williams LE; Primus FJ
Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen-transgenic mice: a model for tumor immunotherapy.
Eades-Perner AM; Zimmermann W
Tumour Biol; 1995; 16(1):56-61. PubMed ID: 7863223
[TBL] [Abstract][Full Text] [Related]
12. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
[TBL] [Abstract][Full Text] [Related]
14. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
Aarts WM; Schlom J; Hodge JW
Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
[TBL] [Abstract][Full Text] [Related]
15. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
[TBL] [Abstract][Full Text] [Related]
16. T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice.
Chmielewski M; Hahn O; Rappl G; Nowak M; Schmidt-Wolf IH; Hombach AA; Abken H
Gastroenterology; 2012 Oct; 143(4):1095-107.e2. PubMed ID: 22750462
[TBL] [Abstract][Full Text] [Related]
17. T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells.
Rössler U; Andres AC; Reichmann E; Schmahl W; Werenskiold AK
Oncogene; 1993 Mar; 8(3):609-17. PubMed ID: 8437844
[TBL] [Abstract][Full Text] [Related]
18. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
Huang Y; Fayad R; Smock A; Ullrich AM; Qiao L
Cancer Res; 2005 Aug; 65(15):6990-9. PubMed ID: 16061685
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
20. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
